Beauty Farm Medical and Health Industry Inc. (Beauty Farm) disclosed that on 22 May 2026 it repurchased 22,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HK$19.70 to HK$19.86, for a total consideration of HK$0.44 million.

Following the transaction, issued shares outstanding (excluding treasury shares) fell by 0.0088% to 249.39 million. Treasury shares increased to 2.21 million, while the company’s total issued share count remained unchanged at 251.59 million because the repurchased shares have been retained as treasury stock rather than cancelled.

The buyback was conducted under the share-repurchase mandate approved on 27 June 2025, which authorises the company to repurchase up to 23.58 million shares. Cumulative repurchases under this mandate now stand at 2.21 million shares, equivalent to 0.94% of the company’s issued share capital as of the mandate date.

In accordance with Hong Kong listing rules, Beauty Farm is subject to a moratorium on issuing new shares or disposing of treasury shares until 21 June 2026.